Charles Schwab Portfolio holdings
Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amgen
AMGN
|
+$793M |
| 2 |
Microsoft
MSFT
|
+$777M |
| 3 |
Coca-Cola
KO
|
+$755M |
| 4 |
Apple
AAPL
|
+$744M |
| 5 |
NVIDIA
NVDA
|
+$718M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard Real Estate ETF
VNQ
|
+$251M |
| 2 |
Vanguard Mortgage-Backed Securities ETF
VMBS
|
+$247M |
| 3 |
Oracle
ORCL
|
+$228M |
| 4 |
Vanguard Long-Term Treasury ETF
VGLT
|
+$176M |
| 5 |
MRO
Marathon Oil Corporation
MRO
|
+$140M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.59% |
| 2 | Financials | 12.77% |
| 3 | Consumer Discretionary | 9.88% |
| 4 | Healthcare | 9.85% |
| 5 | Industrials | 8.27% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
BDN
1726
Brandywine Realty Trust
BDN
$524M
| $19.1M | ﹤0.01% |
3,419,033
-708,641
| -17% | -$3.95M |
|
1727
Nomad Foods
NOMD
$1.66B
| $19.1M | ﹤0.01% |
1,140,867
+114,026
| +11% | +$1.99M |
|
|
PMT
1728
PennyMac Mortgage Investment
PMT
$822M
| $19.1M | ﹤0.01% |
1,520,394
+63,781
| +4% | +$863K |
|
1729
NeoGenomics
NEO
$1.96B
| $19.1M | ﹤0.01% |
1,161,352
+26,701
| +2% | +$415K |
|
1730
Arrowhead Research
ARWR
$11.9B
| $19.1M | ﹤0.01% |
1,017,720
+10,785
| +1% | +$222K |
|
1731
Check Point Software Technologies
CHKP
$13B
| $19M | ﹤0.01% |
101,931
-20,815
| -17% | -$3.92M |
|
1732
nCino
NCNO
$2.02B
| $19M | ﹤0.01% |
566,627
+9,870
| +2% | +$368K |
|
1733
State Street Industrial Select Sector SPDR ETF
XLI
$33.3B
| $19M | ﹤0.01% |
143,909
-36,714
| -20% | -$5.06M |
|
1734
FIVE9
FIVN
$2.11B
| $18.9M | ﹤0.01% |
465,702
+8,445
| +2% | +$305K |
|
1735
Fox Factory Holding Corp
FOXF
$755M
| $18.9M | ﹤0.01% |
622,745
+73,110
| +13% | +$2.52M |
|
1736
SAP
SAP
$212B
| $18.8M | ﹤0.01% |
76,495
+10,763
| +16% | +$2.56M |
|
1737
Adient
ADNT
$1.65B
| $18.8M | ﹤0.01% |
1,091,272
+127,826
| +13% | +$2.55M |
|
|
LADR
1738
Ladder Capital
LADR
$1.21B
| $18.8M | ﹤0.01% |
1,678,115
+45,040
| +3% | +$517K |
|
|
RYZ
1739
Ryerson Holding Corp
RYZ
$1.44B
| $18.8M | ﹤0.01% |
1,014,110
+166,596
| +20% | +$3.74M |
|
1740
DoubleVerify
DV
$1.73B
| $18.7M | ﹤0.01% |
973,147
+71,000
| +8% | +$1.34M |
|
1741
Coca-Cola Europacific Partners
CCEP
$48.3B
| $18.6M | ﹤0.01% |
241,877
-8,787
| -4% | -$679K |
|
1742
Transmedics
TMDX
$2.64B
| $18.5M | ﹤0.01% |
297,433
+25,739
| +9% | +$2.4M |
|
1743
Sotera Health
SHC
$5.09B
| $18.4M | ﹤0.01% |
1,347,195
-1,722
| -0.1% | -$25K |
|
1744
IDEAYA Biosciences
IDYA
$3.42B
| $18.3M | ﹤0.01% |
712,811
+23,738
| +3% | +$672K |
|
1745
Ligand Pharmaceuticals
LGND
$5.76B
| $18.3M | ﹤0.01% |
170,419
+6,495
| +4% | +$734K |
|
|
TWO
1746
Two Harbors Investment
TWO
$1.27B
| $18.2M | ﹤0.01% |
1,542,458
+57,915
| +4% | +$701K |
|
1747
JELD-WEN Holding
JELD
$122M
| $18.2M | ﹤0.01% |
2,225,439
+220,815
| +11% | +$2.66M |
|
1748
UL Solutions
ULS
$18.5B
| $18.2M | ﹤0.01% |
365,324
+22,617
| +7% | +$1.17M |
|
1749
Vera Therapeutics
VERA
$2.3B
| $18.2M | ﹤0.01% |
430,665
+68,860
| +19% | +$3.05M |
|
1750
Jack in the Box
JACK
$312M
| $18.2M | ﹤0.01% |
436,361
+47,851
| +12% | +$2.21M |
|
Similar funds
Charles Schwab's Q4 2024 Portfolio in Review
As of Q4 2024, Charles Schwab held 3,563 positions worth $542B, up 3.5% from $524B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Charles Schwab deployed $17.7B of net new capital in Q4 2024, opening 62 new positions and adding to 2,296 existing holdings. Its largest new stake was Janus Henderson AAA CLO ETF: 3,465,261 shares worth $176M.
By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 23% a quarter earlier, followed by Financials and Consumer Discretionary.
On the sell side, the largest reduction was Vanguard Mortgage-Backed Securities ETF, an estimated $247M trimmed.
- Charles Schwab's largest Q4 2024 buy was Janus Henderson AAA CLO ETF: 3,465,261 shares worth $176M.
- Charles Schwab added most to Amgen in Q4 2024, an estimated $793M increase.
- Charles Schwab's biggest Q4 2024 reduction was Vanguard Mortgage-Backed Securities ETF, cutting an estimated $247M.
- Charles Schwab fully exited Vanguard Real Estate ETF in Q4 2024, selling an estimated $251M.
- Charles Schwab's ten largest holdings make up 23% of its $542B portfolio in Q4 2024.
- Charles Schwab opened 62 new positions and closed 70 in Q4 2024.
- Charles Schwab's portfolio value rose 3.5% quarter-over-quarter to $542B.
Based on Charles Schwab's 13F filing for Q4 2024, filed 6 Feb 2025.